BP Lipid 229 is an amino ionizable lipid designed for comparative studies with ALC-0315 in formulation development. Featuring an ethanolamine-derived amino head group, this lipid enhances mRNA encapsulation efficiency. It possesses primary esters at the C7 position relative to the amine nitrogen and includes an 8-carbon primary lipid tail. BP Lipid 229 is suitable for mRNA-based therapeutic applications that require a safe and effective delivery system. Reagent grade – for research use only. For inquiries regarding GMP-grade material, please contact us.
Usually ships within 24 hours.